Mercer Global Advisors
DFTX

Mercer Global Advisors’s Definium Therapeutics DFTX Stock Holding History

Mercer Global Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$483K Buy
+10,278
New +$254K ﹤0.01% 2322
2026
Q1 		– Sell
-20,392
Closed -$273K – 3304
2025
Q4 		$273K Sell
20,392
-1,539
-7% -$19K ﹤0.01% 2309
2025
Q3 		$259K Buy
21,931
+2,079
+10% +$19.4K ﹤0.01% 2198
2025
Q2 		$129K Buy
19,852
+272
+1% +$1.79K ﹤0.01% 2129
2025
Q1 		$115K Buy
19,580
+3,580
+22% +$25.6K ﹤0.01% 2047
2024
Q4 		$111K Sell
16,000
-520
-3% -$3.58K ﹤0.01% 2029
2024
Q3 		$93K Buy
16,520
+2,000
+14% +$13.9K ﹤0.01% 1887
2024
Q2 		$105K Sell
14,520
-408
-3% -$3.57K ﹤0.01% 1870
2024
Q1 		$140K Buy
+14,928
New +$85.1K ﹤0.01% 1829

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Mercer Global Advisors's DFTX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 10,278 shares worth $483K. The stake represents ﹤0.01% of the portfolio and ranks #2322 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in DFTX as recently as Q4 2025.

Mercer Global Advisors first reported a position in DFTX in Q1 2024 and has held it in 9 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Mercer Global Advisors held 10,278 shares of Definium Therapeutics worth $483K as of Q2 2026.
  • Definium Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2322 holding.
  • Mercer Global Advisors first reported a position in Definium Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.